Alcon AG vs Amplify Transformational Data Sharing ETF — how do they compare? Alcon AG trades at $72.78 (market cap $36.44B), while Amplify Transformational Data Sharing ETF trades at $59.16. The key difference: Alcon AG pays a 0.48% dividend while Amplify Transformational Data Sharing ETF pays none. Which is the better fit depends on your goals.
| ALC | BLOK | |
|---|---|---|
Market Cap | $36.44B | — |
Sector | Health | — |
52-Week High | $90.12 | $74.10 |
52-Week Low | $62.02 | $47.36 |
Enterprise Value | $40.28B | — |
Dividend Yield | 0.48% | — |
Trailing returns across standard periods
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →The fund is an actively managed ETF that seeks to provide total return by investing at least 80% of its net assets in the equity securities of companies actively involved in the development and utilization of "transformational data sharing technologies". It may invest in non-US equity securities, including depositary receipts.
Read more on BLOK →